Compound ID | 746

FMA199

Class: Macrolide

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Protein synthesis inhibitor
Target Pathogen: Active against Streptococcus sp.
Description: An erythromycin derivative
Institute where first reported: Taisho Pharmaceuticals
Year first mentioned: 1999
Development status: Experimental

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.